...
首页> 外文期刊>BMC Urology >Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome
【24h】

Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome

机译:89例膀胱肠上皮化生:一项针对长期预后的研究

获取原文
           

摘要

Background Intestinal metaplasia of the bladder is an uncommon glandular proliferation. We examined a large series of intestinal metaplasia for the clinicopathological features and discuss the significance of this lesion. Methods All cases of intestinal metaplasia diagnosed in our institution between 1990 and 2014 were retrospectively reviewed. Patients with a history of urothelial carcinoma or concurrent adenocarcinoma were excluded. Patient characteristics, pathological features, and follow-up outcomes were obtained. Results We identified 89 patients with intestinal metaplasia during this period. Sixty seven were men and 22 were women. Mean age at diagnosis was 57?years (range 23–81). Common presenting complaints included haematuria (73 cases), mucosuria (13 cases), and irritative voiding symptoms (seven cases). The majority of intestinal metaplasias located on or near the trigone (67 cases). Eighty-two patients underwent transurethral resection of their lesions. Partial cystectomy was performed in the remaining seven patients. The mean follow-up of 78 patients was 105?months (range 6–255). One case of bladder adenocarcinoma was indentified 6?months later. The initial histologic findings had revealed intestinal metaplasia with severe dysplasia. Four patients presented recurrence during the follow-up, and this occurred 9, 13, 17 and 24?months after the surgery. Conclusions Although intestinal metaplasia can be treated effectively by transurethral resection in most cases, its potential malignancy need to be taken into consideration after the evidence of recurrences and its association with bladder adenocarcinoma. Therefore, it is necessary to perform close surveillance following the surgery, particularly in patients with dysplastic changes.
机译:背景膀胱的肠上皮化生是罕见的腺体增生。我们检查了一系列肠上皮化生的临床病理特征,并讨论了该病变的重要性。方法回顾性分析1990年至2014年在我院确诊的所有肠上皮化生病例。有尿路上皮癌或并发腺癌病史的患者被排除在外。获得了患者特征,病理特征和随访结果。结果我们确定了89例在此期间出现肠上皮化生的患者。男性为67人,女性为22人。诊断时的平均年龄为57岁(23-81岁)。常见的主诉包括血尿(73例),黏膜尿症(13例)和刺激性排尿症状(7例)。大部分肠上皮化生位于三角骨上或附近(67例)。八十二例患者行经尿道切除术。其余7例患者进行了部分膀胱切除术。 78例患者的平均随访时间为105个月(6-255)。 6个月后发现1例膀胱腺癌。最初的组织学发现显示肠上皮化生伴严重的异型增生。 4例患者在随访期间出现复发,发生在术后9、13、17和24个月。结论尽管大多数情况下经尿道切除可有效治疗肠上皮化生,但在复发证据及其与膀胱腺癌的相关性后,仍需考虑其潜在的恶性肿瘤。因此,有必要在手术后进行严密监视,特别是对于发育异常改变的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号